Aphakia
57
2
5
42
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
25 trials with published results (44%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
3.5%
2 terminated out of 57 trials
95.5%
+8.9% vs benchmark
7%
4 trials in Phase 3/4
60%
25 of 42 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 42 completed trials
Clinical Trials (57)
Comparison of the Hoya Surgical Optics (HSO) iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical / Literature Controls.
Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
Feasibility Study of an Accommodating IOL Design
Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL
Contralateral Claims Study of Clareon Vivity Pro
Clareon Toric Study (T2-T9)
Clinical Evaluation of a Novel Trifocal IOL
Clareon TruPlus Study
Clareon PanOptix Pro vs. Clareon PanOptix - Study B
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
Evaluation of Long-term Safety and Performance of PanOptix Trifocal Intraocular Lens (IOL)
Evaluation of Clareon Vivity/Vivity Toric
Clareon PanOptix Pro vs. Clareon PanOptix - Study A
Evaluation of AcrySof IQ Vivity Extended Vision Intraocular Lenses
A Real-World Evidence (RWE) Long-Term Follow-Up Study to Assess Outcomes of Alcon Monofocal Intraocular Lenses
RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study
Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjustable Lens (LAL) And The Light Delivery Device (LDD) To Improve Visual Outcomes
A Clinical Study to Evaluate The Safety and Effectiveness of The RxSight Light Adjustable Lens (LAL) In Subjects Desiring an Extended Depth of Focus
Clareon Toric vs Eyhance Toric